King Pharmaceuticals®, Inc. Posts Q4 Loss on Charge, Lower Sales

February 26, 2009 |

1 min read

BOSTON, Feb 26 (Reuters) - King Pharmaceuticals Inc posted a fourth-quarter loss on Thursday as sales of its blood pressure drug fell and it took an acquisition-related charge.

Earnings

MORE ON THIS TOPIC

Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo

Venture capital

Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America

December 16, 2025

·

1 min read

·

Annalee Armstrong

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Pfizer, Geron Downsize To Streamline Costs

December 12, 2025

·

95 min read

·

BioSpace Editorial Staff